SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sara R. Teixeira, Claudia Martinez-Rios, Lingzhi Hu, Barbara A. Bangert, Clinical Applications of Pediatric Positron Emission Tomography-Magnetic Resonance Imaging, Seminars in Roentgenology, 2014, 49, 4, 353

    CrossRef

  2. 2
    Abby R. Rosenberg, James R. Anderson, Elizabeth Lyden, David A. Rodeberg, Suzanne L. Wolden, Simon C. Kao, David M. Parham, Carola Arndt, Douglas S. Hawkins, Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: A report from the Children’s Oncology Group, European Journal of Cancer, 2014, 50, 4, 816

    CrossRef

  3. 3
    L. de Mestier, C. Dromain, G. d'Assignies, J.-Y. Scoazec, N. Lassau, R. Lebtahi, H. Brixi, E. Mitry, R. Guimbaud, F. Courbon, M. d'Herbomez, G. Cadiot, Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art, Endocrine Related Cancer, 2014, 21, 3, R105

    CrossRef

  4. 4
    Colleen M. Costelloe, Hubert H. Chuang, John E. Madewell, FDG PET/CT of Primary Bone Tumors, American Journal of Roentgenology, 2014, 202, 6, W521

    CrossRef

  5. 5
    Anna Frezza, Tim Beale, Jamshed Bomanji, Amrita Jay, Nicholas Kalavrezos, Palma Dileo, Jeremy Whelan, Sandra J Strauss, Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?, BMC Cancer, 2014, 14, 1, 23

    CrossRef

  6. 6
    Sonia R. Skamene, Rajan Rakheja, Kristina R. Dalhstrom, David Roberge, Ayoub Nahal, Mathieu Charest, Robert Turcotte, Marc Hickeson, Carolyn Freeman, Metabolic activity measured on PET/CT correlates with clinical outcomes in patients with limb and girdle sarcomas, Journal of Surgical Oncology, 2014, 109, 5
  7. 7
    Dana L. Casey, Leonard H. Wexler, Josef J. Fox, Kavita V. Dharmarajan, Heiko Schoder, Alison N. Price, Suzanne L. Wolden, Predicting Outcome in Patients with Rhabdomyosarcoma: Role of [18F]Fluorodeoxyglucose Positron Emission Tomography, International Journal of Radiation Oncology*Biology*Physics, 2014, 90, 5, 1136

    CrossRef

  8. 8
    Jin-peng He, Yun Hao, Mi Li, Jiang Wang, Feng-jin Guo, Tumor-to-background Ratio to Predict Response to Chemotherapy of Osteosarcoma Better than Standard Uptake Values, Orthopaedic Surgery, 2014, 6, 2
  9. 9
    Chang-Bae Kong, Byung Hyun Byun, Ilhan Lim, Chang Woon Choi, Sang Moo Lim, Won Seok Song, Wan Hyeong Cho, Dae-Geun Jeon, Jae-Soo Koh, Ji Young Yoo, Soo-Yong Lee, 18F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma, European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40, 5, 728

    CrossRef

  10. 10
    Douglas S. Hawkins, Sheri L. Spunt, Stephen X. Skapek, Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas, Pediatric Blood & Cancer, 2013, 60, 6
  11. 11
    Winston W. Huh, Nancy E. Fitzgerald, Anita Mahajan, Andrea Hayes-Jordan, Peritoneal sarcomatosis in pediatric malignancies, Pediatric Blood & Cancer, 2013, 60, 1
  12. 12
    Andrei Iagaru, Phillip Young, Erik Mittra, David W. Dick, Robert Herfkens, Sanjiv Sam Gambhir, Pilot Prospective Evaluation of 99mTc-MDP Scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and Whole-Body MRI for Detection of Skeletal Metastases, Clinical Nuclear Medicine, 2013, 38, 7, e290

    CrossRef

  13. 13
    Heather Magnan, Sara J. Abramson, Anita P. Price, Ravinder K. Grewal, Melinda S. Merchant, Michael P. LaQuaglia, Paul A. Meyers, Positron Emission Tomography for Response Assessment in Desmoplastic Small Round Cell Tumor, Journal of Pediatric Hematology/Oncology, 2013, 35, 5, e190

    CrossRef

  14. 14
    Patrick J. Peller, Role of Positron Emission Tomography/Computed Tomography in Bone Malignancies, Radiologic Clinics of North America, 2013, 51, 5, 845

    CrossRef

  15. 15
    Kuntal A. Rana, John Meyer, Saman Ibrahim, Michael Ralls, Paul M. Kent, The role of imaging of malignant bone tumors in children and young adults, Current Problems in Cancer, 2013, 37, 4, 181

    CrossRef

  16. 16
    Kevin London, Claudia Stege, Siobhan Cross, Ella Onikul, Nicole Graf, Gertjan Kaspers, Luciano Dalla-Pozza, Robert Howman-Giles, 18F-FDG PET/CT compared to conventional imaging modalities in pediatric primary bone tumors, Pediatric Radiology, 2012, 42, 4, 418

    CrossRef

  17. 17
    G. Grignani, E. Palmerini, P. Dileo, S. D. Asaftei, L. D'Ambrosio, Y. Pignochino, M. Mercuri, P. Picci, F. Fagioli, P. G. Casali, S. Ferrari, M. Aglietta, A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study, Annals of Oncology, 2012, 23, 2, 508

    CrossRef

  18. 18
    Carola A.S. Arndt, Peter S. Rose, Andrew L. Folpe, Nadia N. Laack, Common Musculoskeletal Tumors of Childhood and Adolescence, Mayo Clinic Proceedings, 2012, 87, 5, 475

    CrossRef

  19. 19
    Junyu Guo, Wilburn E. Reddick, John O. Glass, Qing Ji, Catherine A. Billups, Jianrong Wu, Fredric A. Hoffer, Sue C. Kaste, Jesse J. Jenkins, Ximena C. Ortega Flores, Juan Quintana, Milena Villarroel, Najat C. Daw, Dynamic contrast-enhanced magnetic resonance imaging as a prognostic factor in predicting event-free and overall survival in pediatric patients with osteosarcoma, Cancer, 2012, 118, 15
  20. 20
    Manabu Hoshi, Jun Takada, Naoto Oebisu, Kanako Hata, Makoto Ieguchi, Hiroaki Nakamura, Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT, Archives of Orthopaedic and Trauma Surgery, 2012, 132, 11, 1561

    CrossRef

  21. 21
    Kavita V. Dharmarajan, Leonard H. Wexler, Somali Gavane, Josef J. Fox, Heiko Schoder, Ashlyn K. Tom, Alison N. Price, Paul A. Meyers, Suzanne L. Wolden, Positron Emission Tomography (PET) Evaluation After Initial Chemotherapy and Radiation Therapy Predicts Local Control in Rhabdomyosarcoma, International Journal of Radiation Oncology*Biology*Physics, 2012, 84, 4, 996

    CrossRef

  22. 22
    Hyung Jun Im, Tae Sung Kim, Seog-Yun Park, Hye Sook Min, June Hyuk Kim, Hyun Guy Kang, Seung Eun Park, Mi Mi Kwon, Jong Hyung Yoon, Hyeon Jin Park, Seok-ki Kim, Byung-Kiu Park, Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma, European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39, 1, 39

    CrossRef

  23. 23
    Suman Malempati, Douglas S. Hawkins, Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies, Pediatric Blood & Cancer, 2012, 59, 1
  24. 24
    Anri Inaki, Junichi Taki, Hiroshi Wakabayashi, Hisashi Sumiya, Yoh Zen, Hiroyuki Tsuchiya, Seigo Kinuya, Thallium-201 scintigraphy for the assessment of long-term prognosis in patients with osteosarcoma, Annals of Nuclear Medicine, 2012, 26, 7, 545

    CrossRef

  25. 25
    Carmelo Caldarella, Marco Salsano, Maria Antonietta Isgrò, Giorgio Treglia, The Role of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Assessing the Response to Neoadjuvant Treatment in Patients with Osteosarcoma, International Journal of Molecular Imaging, 2012, 2012, 1

    CrossRef

  26. 26
    C. Baunin, G. Schmidt, K. Baumstarck, C. Bouvier, J. C. Gentet, A. Aschero, A. Ruocco, B. Bourlière, G. Gorincour, C. Desvignes, N. Colavolpe, G. Bollini, P. Auqier, P. Petit, Value of diffusion-weighted images in differentiating mid-course responders to chemotherapy for osteosarcoma compared to the histological response: preliminary results, Skeletal Radiology, 2012, 41, 9, 1141

    CrossRef

  27. 27
    Louie L. Gaston, Claudia Di Bella, John Slavin, Rodney J. Hicks, Peter F. M. Choong, 18F-FDG PET response to neoadjuvant chemotherapy for Ewing sarcoma and osteosarcoma are different, Skeletal Radiology, 2011, 40, 8, 1007

    CrossRef

  28. 28
    Franziska Walter, Noah Federman, Wipapat Apichairuk, Scott Nelson, Michael E. Phelps, Martin Allen-Auerbach, Martin A. Walter, Johannes Czernin, 18F-FluoroDeoxyGlucose Uptake of Bone and Soft Tissue Sarcomas in Pediatric Patients, Pediatric Hematology-Oncology, 2011, 28, 7, 579

    CrossRef

  29. 29
    Elske Quak, Addy CM van de Luijtgaarden, Lioe-Fee de Geus-Oei, Winette TA van der Graaf, Wim JG Oyen, Clinical applications of positron emission tomography in sarcoma management, Expert Review of Anticancer Therapy, 2011, 11, 2, 195

    CrossRef

  30. 30
    Sue C. Kaste, Imaging Pediatric Bone Sarcomas, Radiologic Clinics of North America, 2011, 49, 4, 749

    CrossRef

  31. 31
    Stephan D. Voss, Pediatric oncology and the future of oncological imaging, Pediatric Radiology, 2011, 41, S1, 172

    CrossRef

  32. 32
    Winston W. Huh, Nancy Fitzgerald, Anita Mahajan, Erich M. Sturgis, R. Beverly Raney, Peter M. Anderson, Pediatric sarcomas and related tumors of the head and neck, Cancer Treatment Reviews, 2011, 37, 6, 431

    CrossRef

  33. 33
    Erik Mittra, Andrei Iagaru, 18F-FDG-PET and PET/CT for Evaluating Primary Bone Tumors, PET Clinics, 2010, 5, 3, 327

    CrossRef

  34. 34
    Frederick D. Grant, Laura A. Drubach, S. Ted Treves, 18F-Fluorodeoxyglucose PET and PET/CT in Pediatric Musculoskeletal Malignancies, PET Clinics, 2010, 5, 3, 349

    CrossRef

  35. 35
    Timm Denecke, Patrick Hundsdörfer, Daniel Misch, Ingo G. Steffen, Stefan Schönberger, Christian Furth, Michail Plotkin, Juri Ruf, Hubertus Hautzel, Brigitte Stöver, Regine Kluge, Uta Bierbach, Sylke Otto, James F. Beck, Christiane Franzius, Günter Henze, Holger Amthauer, Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters, European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37, 10, 1842

    CrossRef

  36. 36
    Heather Magnan, Alexander J. Chou, Joanne F. Chou, Henry W.D. Yeung, John H. Healey, Paul A. Meyers, Noninvasive imaging with thallium-201 scintigraphy may not correlate with survival in patients with osteosarcoma, Cancer, 2010, 116, 17
  37. 37
    Sameer Bakhshi, Venkatraman Radhakrishnan, Prognostic markers in osteosarcoma, Expert Review of Anticancer Therapy, 2010, 10, 2, 271

    CrossRef

  38. 38
    Chang-Bae Kong, Soo-Yong Lee, Dae-Geun Jeon, Staged Lengthening Arthroplasty for Pediatric Osteosarcoma around the Knee, Clinical Orthopaedics and Related Research®, 2010, 468, 6, 1660

    CrossRef

  39. 39
    David M. Loeb, Robert F. Hobbs, Amarachukwu Okoli, Allen R. Chen, Steve Cho, Senthamizhchelvan Srinivasan, George Sgouros, Ori Shokek, Moody D. Wharam, Tammy Scott, Cindy L. Schwartz, Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma, Cancer, 2010, 116, 23